期刊文献+

塞来西布及5-氟尿嘧啶对人胆管癌QBC939细胞生长抑制及诱导凋亡的影响

Effect of Celecoxib and 5-FU on Proliferation and Apoptosis of the Human Cholangiocarcinoma QBC-939 Cell Line
原文传递
导出
摘要 目的:研究塞来西布(Celecoxib)和5-氟尿嘧啶(5-FU)对人胆管癌QBC939细胞生长抑制和凋亡的影响。方法:体外培养人胆管癌QBC939细胞,噻唑兰比色实验(MTT)观察Celecoxib和5-FU对胆管癌QBC939细胞生长抑制作用;流式细胞术检测细胞生长周期和凋亡率改变。结果:不同浓度的Celecoxib和5-FU可抑制胆管癌QBC939细胞的生长,细胞生长抑制率呈时间-浓度依赖性(P<0.01);实验组QBC939细胞凋亡率随药物浓度的升高逐渐增高(P<0.01),S期细胞逐渐减少(P<0.05),G1期细胞逐渐增加(P<0.05),G2期细胞无明显变化。结论:Celecoxib和5-FU可抑制人胆管癌QBC939细胞的增殖,诱导其凋亡;联合用药效果优于Celecoxib和5-FU单药效果。 Objective:To investigate the effect of Celecoxib and 5-FU on proliferation and apoptosis in human cholangiocarcinoma QBC939 cells line in vitro.Methods:QBC939 cells line were treated with different concentration of Celecoxib or 5-FU,then the inhibition rate of cell growth were detected by MTT and apoptosis index and cell cycle arrest detected by flowcytometer.Results:Different concentration of Celecoxib and 5-FU can inhibit proliferation of QBC939 cells line.The inhibitation effect depends on time and concentration(P〈0.01);The apoptosis index of QBC939 gradually increase with the increase of drug concentration(P〈0.01),S stage cell decreases gradually while G1 stage cell increases(P〈0.05),G2 stage cell ratio has no obvious change.Conclusions :Celecoxib and 5-FU inhibits proliferation of QBC939 cells line and induce apoptosis in vitro.Combination Celecoxib with 5-FU therapy is better than alone.
出处 《现代生物医学进展》 CAS 2012年第3期456-459,434,共5页 Progress in Modern Biomedicine
关键词 塞来西布 5-氟尿嘧啶 胆管癌 细胞凋亡 细胞周期 Celecoxib 5-FU Cholangiocarcinoma Apoptosis Cell cycle
  • 相关文献

参考文献2

二级参考文献19

  • 1Yun-Lin Wu~1 Bo Sun~1 Xue-Jun Zhang~2 Sheng-Nian Wang~2 Heng-Yi He~2 Min-Min Qiao~1 Jie Zhong~1 Jia-Yu Xu~1 1 Department of Gastroenterology,Ruijin Hospital,Shanghai Second Medical University,Shanghai 200025,China2 Institude of Biochemistry and Cell Biology,Shanghai Institues for Biological Sciences,Chinese Academy of Sciences.Shanghai 200025,China.Growth inhibition and apoptosis induction Sulindac on Human gastric cancer cells[J].World Journal of Gastroenterology,2001,7(6):796-800. 被引量:64
  • 2胡伏莲 周殿元 贾博琦主编.幽门螺杆菌感染的基础与临床:第3版[M].北京:中国科学技术出版社,2000.299~299.
  • 3Zimmermann KC, Sarbia M, Weber AA, et al. Cyclooxygenase-2 expression in human esophageal carcinoma [J]. Cancer Res, 1999,59(1): 198.
  • 4Tsujii M, Kawano S,Tsuji S,et al. Cyclooxygenase regulates angiogenesis induced by colon cancer cells [J]. Cell, 1998 , 93(5): 705.
  • 5Tomozawa S, Nagawa H, Tsuno N, et al. Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor,JTE-522 [J]. Br J Cancer, 1999, 81(8) : 1274.
  • 6Sheehan KM, Sheahan K, O' Donoghue DP, et al. The relationship between cyclooxygenase-2 expression and colorectal cancer [J]. JAMA,1999, 282(13): 1254.
  • 7Ristimaki A, Honkanen N ,Jankala H, et al. Expression cyelooxygenase-2 in human gastric carcinoma [JT. Cancer Res, 1997, 57 (7) :1276.
  • 8Hack HM, Fennerty MB, Sampliner R,et al. Apprent reverse of intestinal metaplasia after treatment of H. pylori infection [J]. Gastroenterology,1994, 106(4) : A87.
  • 9Borody TJ ,Clark IW,Andrews P,et al. Eradication of Helicobacter pylori may not reverse severe gastric dysplasia [J]. Am J Gastroenterol,1995, 90(3): 498.
  • 10McCarthy CJ,Crofford LJ, Greenson J, et al. Cyclooxygenase-2 expression in gastric antral mucosa before and after eradication of Helicobacter pylori infection [J]. Am J Gastroenterol, 1999 , 94 (5) :1218.

共引文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部